Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Catching TK2D sooner starts with knowing what to look for. Experts say red flags like short stature, slow weight gain, and gastrointestinal symptoms — especially alongside muscle weakness — should prompt mitochondrial screening. Whole exome or genome sequencing is now the first-line confirmatory test, and getting there faster can meaningfully shorten the diagnostic odyssey for affected children and their families.
TK2 deficiency (TK2D) is a rare mitochondrial muscle disease that often goes undiagnosed for years — partly because its early signs can be subtle or mistaken for other conditions. Experts Dr. Michio Hirano and Dr. Zarazuela Zolkipli-Cunningham highlight that the loss of motor milestones — such as a child suddenly losing the ability to walk independently — is a major red flag that should trigger a workup for neurodegenerative or mitochondrial disorders, typically presenting around ages three to five.
Clinicians are urged to actively ask about a history of failure to thrive, low growth percentiles, or slow weight gain — details parents may not volunteer. When muscle symptoms are accompanied by involvement of a second organ system, particularly mild gastrointestinal issues, the picture points beyond isolated muscle disease toward a systemic energy disorder like TK2D.
Key Takeaways
Why it matters: Earlier recognition of TK2D red flags and faster access to genetic testing can dramatically shorten the diagnostic odyssey, giving families answers sooner and opening the door to timely management and support.
